Holmium laser enucleation of the prostate (HoLEP) in short‐circuit outpatient care: Is prostatic volume a limiting factor?
LUTS: Lower Urinary Tract Symptoms · 2024
DOI: 10.1111/luts.12525 ↗Kurz gefasst
Beobachtungsstudie in der Zeitschrift LUTS: Lower Urinary Tract Symptoms, 2024. Verfasst von Sánchez Rodríguez Maria und 11 weiteren Autor:innen. Beteiligte Einrichtung: Urology Department, University Hospital Germans Trias i Pujol, Badalona, Spain. Hauptthemen laut MEDLINE: Lasers, Solid-State, Prostatic Hyperplasia, Prostate, Ambulatory Care. Die Arbeit nennt 17 Literaturangaben.
Abstract (Originalsprache)
Introduction and Objectives Our goals were to study prostatic volume as a limiting factor after HoLEP surgery with short‐circuit outpatient care (4 h) and to define other factors that affect the success of the proposed circuit. Materials and Methods An observational analysis and review was performed using a prospective database. Preoperative, intraoperative, and postoperative variables were included for patients who were scheduled for short‐circuit outpatient care (SCOC) and who underwent HoLEP between 2020 and 2023. We defined SCOC as a postoperative hospital stay of 4 h. Subjects who required more than 4 h in hospital were categorized as conventional hospital admission (CHA). A descriptive populational study was conducted, expressing the mean using a 95% confidence interval and percentages for the continuous variables. In order to analyze them, we used the Student's t ‐test for the continuous variables and the chi‐squared test for the categorical variables.
Results
Sixty‐eight patients were included, 54 of which completed SCOC, which represented a success ratio of 79.5%. The mean age and prostatic volume of the whole cohort were 68.9 (±6.8) years and 79.5 (±29.1) mL, respectively. We found no significant differences in age, prostatic volume, antiplatelet drug use, indwelling bladder catheter, or applied energy among the subjects who completed SCOC and those who required CHA. No patient was presented with a complication of Grade 3 (or higher) in the modified Clavien–Dindo classification. At the six‐month follow‐up, no differences were observed in the uroflowmetry or International Prostate Symptoms Score variables.
Conclusions
Prostatic volume does not seem to be a limiting factor after undergoing HoLEP with short‐circuit outpatient care.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Urology Department, University Hospital Germans Trias i Pujol, Badalona, Spain.
ORCID-Profile: Sánchez Rodríguez Maria
Zitieren
APA
Maria, S. R., Franco, M., Freixa Sala, R., Gasanz Serrano, C., Bernardello Ureta, M., Bultó Gonzalvo, R., Cervera Alcaide, J., Casanova García, C., García Puche, M., Segura Alabart, M., Areal Calama, J. J., & Ágreda Castañeda, F. (2024). Holmium laser enucleation of the prostate (HoLEP) in short‐circuit outpatient care: Is prostatic volume a limiting factor?. LUTS: Lower Urinary Tract Symptoms. https://doi.org/10.1111/luts.12525
Vancouver
Maria SR, Franco M, Freixa Sala R, Gasanz Serrano C, Bernardello Ureta M, Bultó Gonzalvo R, et al. Holmium laser enucleation of the prostate (HoLEP) in short‐circuit outpatient care: Is prostatic volume a limiting factor?. LUTS: Lower Urinary Tract Symptoms. 2024. doi:10.1111/luts.12525
BibTeX
@article{Maria2024,
author = {Maria, Sánchez Rodríguez and Franco, Marco and Freixa Sala, Roger and Gasanz Serrano, Carlos and Bernardello Ureta, Mauro and Bultó Gonzalvo, Ramón and Cervera Alcaide, Jordi and Casanova García, Carla and García Puche, Mireia and Segura Alabart, Maria and Areal Calama, Juan José and Ágreda Castañeda, Fernando},
title = {Holmium laser enucleation of the prostate (HoLEP) in short‐circuit outpatient care: Is prostatic volume a limiting factor?},
journal = {LUTS: Lower Urinary Tract Symptoms},
year = {2024},
doi = {10.1111/luts.12525}
}
EUVIMED